Evidence map›Paper›PMID 32760911›Full record

ArticleNeuro-oncology advances

Molecular subgrouping of medulloblastoma based on few-shot learning of multitasking using conventional MR images: a retrospective multicenter study.

Xi Chen, Zhen Fan, Kay Ka-Wai Li, Guoqing Wu, Zhong Yang, Xin Gao, Yingchao Liu, Haibo Wu, Hong Chen, Qisheng Tang and 7 more

Abstract read
In one paragraph

Article in Neuro-oncology advances. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Xi ChenDepartment of Electronic Engineering, Fudan University, Shanghai, China.
Zhen FanDepartment of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.
Kay Ka-Wai LiDepartment of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China SAR.
Guoqing WuDepartment of Electronic Engineering, Fudan University, Shanghai, China.
Zhong YangDepartment of Radiology, Huashan Hospital, Fudan University, Shanghai, China.
Xin GaoDepartment of Neurosurgery, Huadong Hospital, Fudan University, Shanghai, China.
Yingchao LiuDepartment of Neurosurgery, Shandong Provincial Hospital, Jinan, China.
Haibo WuDepartment of Pathology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Hong ChenDepartment of Pathology, Huashan Hospital, Fudan University, Shanghai, China.
Qisheng TangDepartment of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.
Liang ChenDepartment of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.
Yuanyuan WangDepartment of Electronic Engineering, Fudan University, Shanghai, China.
Ying MaoDepartment of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.
Ho-Keung NgDepartment of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China SAR.
Zhifeng ShiDepartment of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.
Jinhua YuDepartment of Electronic Engineering, Fudan University, Shanghai, China.
Liangfu ZhouDepartment of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe determination of molecular subgroups-wingless (WNT), sonic hedgehog (SHH), Group 3, and Group 4-of medulloblastomas is very important for prognostication and risk-adaptive treatment strategies. Due to the rare disease characteristics of medulloblastoma, we designed a unique multitask framework for the few-shot scenario to achieve noninvasive molecular subgrouping with high accuracy.

methodsWe introduced a multitask technique based on mask regional convolutional neural network (Mask-RCNN). By effectively utilizing the comprehensive information including genotyping, tumor mask, and prognosis, multitask technique, on the one hand, realized multi-purpose modeling and simultaneously, on the other hand, promoted the accuracy of the molecular subgrouping. One hundred and thirteen medulloblastoma cases were collected from 4 hospitals during the 8-year period in the retrospective study, which were divided into 3-fold cross-validation cohorts (

resultsCompared to the single-task framework, the multitask framework that combined 3 tasks increased the average accuracy of molecular subgrouping from 0.84 to 0.93 in cross-validation and from 0.79 to 0.85 in independent testing. The average area under the receiver operating characteristic curves (AUCs) of molecular subgrouping were 0.97 in cross-validation and 0.92 in independent testing. The average AUCs of prognostication also reached to 0.88 in cross-validation and 0.79 in independent testing. The tumor segmentation results achieved the Dice coefficient of 0.90 in both cohorts.

conclusionsThe multitask Mask-RCNN is an effective method for the molecular subgrouping and prognostication of medulloblastomas with high accuracy in few-shot learning.

Indexed as

few-shot learningmedulloblastomamolecular subgroupingMRIprognosis categorization

Identifiers

PMID32760911
PMCPMC7393307

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.